Northwest Biotherapeutics, Inc. Share Price Other OTC
Equities
NWBO
US66737P6007
Biotechnology & Medical Research
Sales 2022 | 1.68M 134M | Sales 2023 | 1.93M 154M | Capitalization | 822M 65.51B |
---|---|---|---|---|---|
Net income 2022 | -105M -8.37B | Net income 2023 | -62M -4.94B | EV / Sales 2022 | 505 x |
Net Debt 2022 | 19.29M 1.54B | Net Debt 2023 | 43.43M 3.46B | EV / Sales 2023 | 448 x |
P/E ratio 2022 |
-7.59
x | P/E ratio 2023 |
-11.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90% |
Managers | Title | Age | Since |
---|---|---|---|
Linda F. Powers
CEO | Chief Executive Officer | 68 | 16/05/07 |
Alton L. Boynton
FOU | Founder | 79 | 17/03/96 |
Marnix L. Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 31/12/99 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alton L. Boynton
FOU | Founder | 79 | 17/03/96 |
Linda F. Powers
CEO | Chief Executive Officer | 68 | 16/05/07 |
Navid Malik
BRD | Director/Board Member | 55 | 31/03/12 |
1st Jan change | Capi. | |
---|---|---|
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |